Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Dev Immunol ; 2012: 931325, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22489253

RESUMO

BACKGROUND: Combination antiretroviral therapy (cART) has progressively decreased mortality of HIV-associated tuberculosis .To date, however, limited data on tuberculosis treatment outcomes among coinfected patients who are not ART-naive at the time of tuberculosis diagnosis are available. METHODS: A multicenter, observational study enrolled 246 HIV-infected patients diagnosed with tuberculosis, in 96 Italian infectious diseases hospital units, who started tuberculosis treatment. A polytomous logistic regression model was used to identify baseline factors associated with the outcome. A Poisson regression model was used to explain the effect of ART during tuberculosis treatment on mortality, as a time-varying covariate, adjusting for baseline characteristics. RESULTS: Outcomes of tuberculosis treatment were as follows: 130 (52.8%) were successfully treated, 36 (14.6%) patients died in a median time of 2 months (range: 0-16), and 80 (32.6%) had an unsuccessful outcome. Being foreign born or injecting drug users was associated with unsuccessful outcomes. In multivariable Poisson regression, cART during tuberculosis treatment decreased the risk of death, while this risk increased for those who were not ART-naive at tuberculosis diagnosis. CONCLUSIONS: ART during tuberculosis treatment is associated with a substantial reduction of death rate among HIV-infected patients. However, patients who are not ART-naive when they develop tuberculosis remain at elevated risk of death.


Assuntos
Infecções por HIV/tratamento farmacológico , HIV-1/fisiologia , Mycobacterium tuberculosis/fisiologia , Tuberculose Pulmonar/tratamento farmacológico , Adulto , Idoso , Fármacos Anti-HIV/administração & dosagem , Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade/mortalidade , Antituberculosos/administração & dosagem , Antituberculosos/uso terapêutico , Contagem de Linfócito CD4 , Coinfecção , Feminino , Infecções por HIV/microbiologia , Infecções por HIV/mortalidade , Infecções por HIV/virologia , Humanos , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium tuberculosis/efeitos dos fármacos , Análise de Regressão , Taxa de Sobrevida , Resultado do Tratamento , Tuberculose Pulmonar/microbiologia , Tuberculose Pulmonar/mortalidade , Tuberculose Pulmonar/virologia , Carga Viral/efeitos dos fármacos
2.
J Acquir Immune Defic Syndr ; 41(3): 361-4, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16540938

RESUMO

OBJECTIVE: The aim of the study was to analyze the trends in HIV prevalence among childbearing women through unlinked anonymous testing of newborns. METHODS: Dried-blood specimens, residual to routine metabolic screening of newborns, were collected in Italy during the last quarter of each year, from 1994 to 2002. These samples were tested anonymously for HIV antibodies. RESULTS: Of 844,311 specimens tested, 703 (0.83/1000; 95% confidence interval, 0.76-0.88) resulted as HIV antibody-reactive. Prevalence was 1.05 per 1000 in 1994 and decreased significantly over the following 3 years, reaching 0.60 per 1000 in 1997. Thereafter, a seroprevalence increase was recorded with a figure of 1.01 per 1000 in 1999. A decrease was again observed in 2001 and in 2002, when the seroprevalence rate was significantly lower than that recorded in 1994. During the entire study period, higher prevalence rates were observed in northern Italian regions, where the highest AIDS incidence rates are recorded, and in metropolitan compared with nonmetropolitan areas. The estimated number of children born each year to an HIV-positive mother ranged from 313 to 546. CONCLUSION: The number of children born to an HIV-positive mother calls for continued efforts to prevent vertical transmission of the infection.


Assuntos
Infecções por HIV/epidemiologia , Complicações Infecciosas na Gravidez/epidemiologia , Feminino , Geografia , Anticorpos Anti-HIV/sangue , Soroprevalência de HIV , Humanos , Recém-Nascido , Itália/epidemiologia , Gravidez , Prevalência , População Rural , Estudos Soroepidemiológicos , Fatores de Tempo , População Urbana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...